The non-orally administered triptans

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Migraine, a condition which afflicts 12% of the population, results in substantial pain, hypersensitivities to normal environmental stimuli, nausea/vomiting, disability and enormous costs on individuals and society [1]. Treatments that rapidly and effectively abort migraine attacks are essential in order to limit this migraine burden. Availability of the triptans was a major breakthrough in this regard. Although the orally administered triptans are often the medications of choice when treating migraine, triptans administered by injection, nasal spray, rectal or transdermal routes have some important advantages over the orally administered triptans (Box 3.1). In this chapter, the advantages and disadvantages of the non-orally administered triptans are discussed (Table 3.1).

Original languageEnglish (US)
Title of host publicationTriptans for Migraine
PublisherFuture Medicine Ltd.
Pages33-41
Number of pages9
ISBN (Print)9781780840666, 9781780841335
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The non-orally administered triptans'. Together they form a unique fingerprint.

  • Cite this

    Schwedt, T. J. (2012). The non-orally administered triptans. In Triptans for Migraine (pp. 33-41). Future Medicine Ltd.. https://doi.org/10.2217/EBO.11.177